3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses

Details for Australian Patent Application No. 2007342365 (hide)

Owner Les Laboratoires Servier Cortex Pharmaceuticals, Inc.

Inventors Rogers, Gary; Mueller, Rudolf; Cordi, Alexis

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2007342365

PCT Pub. Number WO2008/085506

Priority 60/878,503 03.01.07 US; 60/921,433 02.04.07 US

Filing date 28 December 2007

Wipo publication date 17 July 2008

International Classifications

A01N 57/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/085506 Priority application(s): WO2008/085506

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007342367-Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

2007342364-3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses